Smart drugs: implications for general practice

Br J Gen Pract. 2017 Mar;67(656):100-101. doi: 10.3399/bjgp17X689437.
No abstract available

Publication types

  • Editorial

MeSH terms

  • General Practice*
  • Humans
  • Illicit Drugs / adverse effects*
  • Illicit Drugs / classification
  • Performance-Enhancing Substances / adverse effects*
  • Performance-Enhancing Substances / classification
  • Practice Guidelines as Topic
  • Review Literature as Topic
  • Substance-Related Disorders / diagnosis*

Substances

  • Illicit Drugs
  • Performance-Enhancing Substances